STING agonists as cancer therapeutics

A Amouzegar, M Chelvanambi, JN Filderman… - Cancers, 2021 - mdpi.com
Simple Summary Immunotherapies have revolutionized the field of cancer therapeutics, yet
a substantial subset of patients fail to respond. Recent efforts have focused on identifying …

[HTML][HTML] Targeting innate immune pathways for cancer immunotherapy

LL Cao, JC Kagan - Immunity, 2023 - cell.com
The innate immune system is critical for inducing durable and protective T cell responses to
infection and has been increasingly recognized as a target for cancer immunotherapy. In this …

Context-dependent functions of pattern recognition receptors in cancer

SM Man, BJ Jenkins - Nature Reviews Cancer, 2022 - nature.com
The immune system plays a critical role in shaping all facets of cancer, from the early
initiation stage through to metastatic disease and resistance to therapy. Our understanding …

[HTML][HTML] STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation

T Nakamura, T Sato, R Endo, S Sasaki… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Resistance to an immune checkpoint inhibitor (ICI) is a major obstacle in cancer
immunotherapy. The causes of ICI resistance include major histocompatibility complex …

Challenges and opportunities in the clinical development of STING agonists for cancer immunotherapy

L Motedayen Aval, JE Pease, R Sharma… - Journal of clinical …, 2020 - mdpi.com
Immune checkpoint inhibitors (ICI) have revolutionised cancer therapy. However, they have
been effective in only a small subset of patients and a principal mechanism underlying …

Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy

J Zheng, J Mo, T Zhu, W Zhuo, Y Yi, S Hu, J Yin… - Molecular cancer, 2020 - Springer
Cellular recognition of microbial DNA is an evolutionarily conserved mechanism by which
the innate immune system detects pathogens. Cyclic GMP-AMP synthase (cGAS) and its …

[HTML][HTML] Genomic instability, inflammatory signaling and response to cancer immunotherapy

M Chen, R Linstra, MATM van Vugt - … et Biophysica Acta (BBA)-Reviews on …, 2022 - Elsevier
Genomic and chromosomal instability are hallmarks of cancer and shape the genomic
composition of cancer cells, thereby determining their behavior and response to treatment …

Disrupted BRCA1‐PALB2 interaction induces tumor immunosuppression and T‐lymphocyte infiltration in HCC through cGAS‐STING pathway

H Ma, Z Kang, TK Foo, Z Shen, B Xia - Hepatology, 2023 - journals.lww.com
Conclusions: This study reveals that persistent DNA damage caused by a defective BRCA
pathway induces tumor immunosuppression and T‐lymphocyte infiltration in HCC through …

Development of cyclopeptide inhibitors of cGAS targeting protein-DNA interaction and phase separation

X Wang, Y Wang, A Cao, Q Luo, D Chen… - Nature …, 2023 - nature.com
Abstract Cyclic GMP-AMP synthase (cGAS) is an essential sensor of aberrant cytosolic DNA
for initiating innate immunity upon invading pathogens and cellular stress, which is …

Harnessing innate immune pathways for therapeutic advancement in cancer

A Hu, L Sun, H Lin, Y Liao, H Yang… - Signal Transduction and …, 2024 - nature.com
The innate immune pathway is receiving increasing attention in cancer therapy. This
pathway is ubiquitous across various cell types, not only in innate immune cells but also in …